Drug Type Small molecule drug |
Synonyms CVI-CT-001 |
Target |
Action agonists |
Mechanism JAK agonists(Janus kinase agonists), PI3Kα agonists(Phosphatidylinositol 3 kinase alpha agonists), TLR agonists(Toll-like receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Preclinical | South Korea | 23 Aug 2024 | |
Colonic Cancer | Preclinical | South Korea | 23 Aug 2024 | |
Prostatic Cancer | Preclinical | South Korea | 23 Aug 2024 | |
Prostatic Cancer | Preclinical | South Korea | 23 Aug 2024 |